| Financial Year |
March 31 2023 |
| Monetary Funds |
36,266,083.25 |
| Held-for-trading Financial Assets |
188,301,768.94 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,463,880.85 |
| Advances to Suppliers |
75,290.71 |
| Other Receivables |
2,496,172.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
18,400.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
501,231,201.21 |
| Total Current Assets |
729,852,797.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,254,539.46 |
| Investment Properties |
-- |
| Fixed Assetes |
34,467,661.98 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
138,097.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
82,314.14 |
| Deferred Income Tax Assets |
17,091,169.51 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
172,096,793.67 |
| Total Assets |
901,949,591.53 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
-- |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,264,982.47 |
| Taxes Payable |
137,385.40 |
| Interest Payable |
-- |
| Dividend Payable |
7,778,521.70 |
| Other payables |
8,509,822.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,048,010.44 |
| Other Current Liabilities |
99,417.92 |
| Sub-Total of Current Liabilities |
18,716,584.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,002,818.82 |
| Total Liabilities |
23,719,402.83 |
| Paid-In Capital(Or Share Stock) |
531,871,494.00 |
| Capital Surplus |
28,139,791.93 |
| Surplus Reserve |
53,075,820.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
238,109,269.83 |
| Minority Stockholder's Interest |
24,062,264.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
854,167,924.03 |
| Owner's Equity（Stockholder's Equity） |
878,230,188.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
901,949,591.53 |
